Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
Lilly Oncology Pipeline icône

1.15.8 by Eli Lilly and Company


Mar 3, 2016

À propos de Lilly Oncology Pipeline

Provides access to the Lilly Oncology Clinical Development Program

For more than five decades, Lilly Oncology has been dedicated to delivering innovative treatment approaches with the goal of improving the outcomes of people living with cancer. We are driven to accelerate the pace and progress of cancer care by developing a portfolio of therapies, including those tailored to unique patients.

Key Features:

- Research: Review areas of research that are being developed by Lilly Oncology

- Clinical Trials: Browse Lilly Oncology clinical trials by area of research, cancer type, or clinical phase, or therapeutic target and access details such as inclusion/exclusion criteria and trial design

- Pathways of Development: Explore molecules that are in development and see mechanism of action videos

- Reference: Save pertinent information for fast and easy reference

Quoi de neuf dans la dernière version 1.15.8

Last updated on Mar 3, 2016

- Content has been updated to reflect latest pipeline information.

Chargement de la traduction...

Informations Application supplémentaires

Dernière version

Demande Lilly Oncology Pipeline mise à jour 1.15.8

Telechargé par

김상원

Nécessite Android

Android 4.4+

Voir plus

Lilly Oncology Pipeline Captures d'écran

Charegement du commentaire...
Abonnez-vous à APKPure
Soyez le premier à avoir accès à la sortie précoce, aux nouvelles et aux guides des meilleurs jeux et applications Android.
Non merci
S'inscrire
Abonné avec succès!
Vous êtes maintenant souscrit à APKPure.
Abonnez-vous à APKPure
Soyez le premier à avoir accès à la sortie précoce, aux nouvelles et aux guides des meilleurs jeux et applications Android.
Non merci
S'inscrire
Succès!
Vous êtes maintenant souscrit à notre newsletter.